Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • incognitos
    Junior Member
    • Sep 2015
    • 9

    Sequencing using custom primer on MiSeq - low diversity?

    I'm planning on sequencing an amplicon library on the MiSeq using a custom primer for read 1 and standard illumine primer for read 2.

    Using a 300 cycle Miseq kit, read 1 length will be 20nt and read 2 length will be 250nt

    The amplicon library is designed as follows
    P5 - barcode/UMI sequence (20nt) - amplicon - nextera adaptor - P7

    Using a custom read1 primer, the 1st 20 bases will be reading the barcode/UMI sequence, which has a good base-balanced design.
    Read2 primer will read the 3'end of the amplicon which will always start with the same 15-20 bases and then have sequence diversity afterwards.

    My question is will this be considered a low diversity library since read2 will always capture the same bases for the first 15-20 bases or is it fine since read1 is base-balanced and the bases in the first read are more important?

    Appreciate any insight that people have!
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    Purity of signals from initial 25 cycles is used for calculation of filtering stats to pass a cluster so you would not be able to do 20 cycles for R1. Read 2 most likely will fail due to low diversity and even the whole sequencing run might stop.

    Comment

    • Brian Bushnell
      Super Moderator
      • Jan 2014
      • 2709

      #3
      You need to use staggered-length inline adapters (this means adapters where part of them, of variable length, is sequenced with the read), or else multiplex your run with something diverse (e.g. PhiX, as a default).

      Comment

      • WhatsOEver
        Senior Member
        • Apr 2012
        • 215

        #4
        We do have a similar problem which we plan to resolve by using "dark" cycles. With this modification of the protocol you simply tell the sequencer to incorporate for example 15nt without "considering" them. This has the advantage that the cluster identification considers nucleotides 15-40 instead of 0-25. The disadvantage is that you will loose the first 15nt.

        Comment

        • niroshan
          Junior Member
          • Jun 2011
          • 9

          #5
          Illumina uses two lasers (green: G/T and red: A/C) to sequence. It is important to maintain color balance for each base of the read being sequenced, otherwise you'll run in difficulties for accurate base calling and run will most likely fail after the first few cycles.

          Comment

          • pmiguel
            Senior Member
            • Aug 2008
            • 2328

            #6
            Originally posted by niroshan View Post
            Illumina uses two lasers (green: G/T and red: A/C) to sequence. It is important to maintain color balance for each base of the read being sequenced, otherwise you'll run in difficulties for accurate base calling and run will most likely fail after the first few cycles.
            Not true. At least not on a MiSeq running a modern version of MCS.

            You do need some signal in each channel. But spiking in 5-10% phiX is sufficient to ensure that -- even if the rest of your libraries are single-plex.

            --
            Phillip

            Comment

            • nucacidhunter
              Jafar Jabbari
              • Jan 2013
              • 1250

              #7
              Originally posted by niroshan View Post
              Illumina uses two lasers (green: G/T and red: A/C) to sequence. It is important to maintain color balance for each base of the read being sequenced, otherwise you'll run in difficulties for accurate base calling and run will most likely fail after the first few cycles.
              It is not true for NextSeq as well. There is no fluorophore attached to G nucleotides in two-channel SBS chemistry and A has two fluorophore. This results in emission from excitation by both lasers for A and no emission from G.

              Comment

              Latest Articles

              Collapse

              • mylaser
                Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by mylaser
                Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
                If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
                This guide explains everything you need to know about...
                Yesterday, 01:13 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              20 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              12 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-07-2026, 11:05 AM
              0 responses
              30 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-02-2026, 11:08 AM
              0 responses
              31 views
              0 reactions
              Last Post SEQadmin2  
              Working...